Search academic texts

Information × Registration Number 2120U006348, Article popup.category Thesis Title popup.author popup.publication 01-01-2020 popup.source_user Сумський державний університет popup.source https://essuir.sumdu.edu.ua/handle/123456789/82104 popup.publisher Elsevier Description In KEYNOTE-010, pembro improved OS vs doce as 2L+ therapy for advanced NSCLC with PD-L1 TPS 1% and 50%. KEYNOTE-010 did not enroll any pts from mainland China, which has high NSCLC mortality. KEYNOTE-033 (NCT02864394) evaluates pembro vs doce in pts with previously treated advanced NSCLC with PD-L1 TPS 1%, with most pts enrolled in mainland China. popup.nrat_date 2025-05-12 Close